Fully human therapeutic monoclonal antibodiesWEINER, Louis M.Journal of immunotherapy (1997). 2006, Vol 29, Num 1, pp 1-9, issn 1524-9557, 9 p.Article

Monoclonal antibodies to epididymis-specific proteins using mice rendered immune tolerant to testicular proteinsJOSHI, Saurabh A; RANPURA, Sandeep A; KHAN, Shagufta A et al.Journal of andrology. 2003, Vol 24, Num 4, pp 524-533, issn 0196-3635, 10 p.Article

Colonization of pepper roots by a plant growth promoting Pseudomonas fluorescens strainGARCIA, J. A; SCHLOTER, M; DURKAYA, T et al.Biology and fertility of soils. 2003, Vol 37, Num 6, pp 381-385, issn 0178-2762, 5 p.Article

Purification of monoclonal antibodies from cell culture supernatants by Gradiflow™ electrophoresis technologyMAHLER, Stephen M; LEONG, Sharon; GILBERT, Andrew et al.Journal of chemical technology and biotechnology (1986). 2006, Vol 81, Num 3, pp 445-453, issn 0268-2575, 9 p.Article

Non-enzymatic hinge region fragmentation of antibodies in solutionCORDOBA, Armando J; SHYONG, Bao-Jen; BREEN, Deirdre et al.Journal of chromatography. B. 2005, Vol 818, Num 2, pp 115-121, issn 1570-0232, 7 p.Article

Industry and regulatory experience of the glycosylation of monoclonal antibodiesREAD, Erik K; PARK, Jun T; BRORSON, Kurt A et al.Biotechnology and applied biochemistry. 2011, Vol 58, pp 213-219, issn 0885-4513, 7 p., 4Article

Monoclonal antibodies : A morphing landscape for therapeuticsNICOLAIDES, Nicholas C; SASS, Philip M; GRASSO, Luigi et al.Drug development research. 2006, Vol 67, Num 10, pp 781-789, issn 0272-4391, 9 p.Article

Quantitative ⁸⁹Zr immuno-PET for in vivo scouting of ⁹⁰Y-labeled monoclonal antibodies in xenograft-bearing nude miceVEREL, Iris; VISSER, Gerard W. M; BOELLAARD, Ronald et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 10, pp 1663-1670, issn 0161-5505, 8 p.Article

Human monoclonal IgM antibodies with apoptotic activity isolated from cancer patientsBRÄNDLEIN, Stephanie; LORENZ, Judith; VOLLMERS, H. Peter et al.Human antibodies. 2002, Vol 11, Num 4, pp 107-119, issn 1093-2607, 13 p.Article

Factors affecting pharmacokinetics of monoclonal antibodies: A review articleIZNAGA-ESCOBAR, N; MISHRA, A. K; PEREZ-RODRIGUEZ, R et al.Methods and findings in experimental and clinical pharmacology. 2004, Vol 26, Num 2, pp 123-127, issn 0379-0355, 5 p.Article

Extending the working range of immunoanalysis by exploitation of two monoclonal antibodiesKRÄMER, Petra M; KREMMER, Elisabeth; FORSTER, Stephan et al.Journal of agricultural and food chemistry (Print). 2004, Vol 52, Num 21, pp 6394-6401, issn 0021-8561, 8 p.Article

Development of monoclonal antibodies specific for Ricinus agglutininsBRANDON, David L; HERNLEM, Bradley J.Food and agricultural immunology. 2009, Vol 20, Num 1, pp 11-22, issn 0954-0105, 12 p.Article

Characterization of rickettsial adhesin Adr2 belonging to a new group of adhesins in α-proteobacteriaVELLAISWAMY, Manohari; KOWALCZEWSKA, Malgorzata; MERHEJ, Vicky et al.Microbial pathogenesis. 2011, Vol 50, Num 5, pp 233-242, issn 0882-4010, 10 p.Article

Development of hybridoma cells producing monoclonal antibody against human epsilon (ε) chainMAJIDI, J; HASSAN, Z. M.Human antibodies. 2003, Vol 12, Num 3, pp 93-98, issn 1093-2607, 6 p.Article

Generation and molecular characterization of a monoclonal antibody reactive with conserved epitope in sphingomyelinases D from Loxosceles spider venomsDIAS-LOPES, C; FELICORI, L; RUBRECHT, L et al.Vaccine. 2014, Vol 32, Num 18, pp 2086-2092, issn 0264-410X, 7 p.Article

Antibody-targeted vaccinesKELER, T; HE, L; RAMAKRISHNA, V et al.Oncogene (Basingstoke). 2007, Vol 26, Num 25, pp 3758-3767, issn 0950-9232, 10 p.Article

Monoclonal antibody-based therapies for microbial diseasesSAYLOR, Carolyn; DADACHOVA, Ekaterina; CASADEVALL, Arturo et al.Vaccine. Supplement. 2009, Vol 27, Num 6, issn 1359-5938, G38-G46Conference Paper

Molecular and immunochemical characteristics of monoclonal and recombinant antibodies specific to bisphenol ANISHI, Kosuke; TAKAI, Mikio; MORIMUNE, Kosuke et al.Bioscience, biotechnology, and biochemistry. 2003, Vol 67, Num 6, pp 1358-1367, issn 0916-8451, 10 p.Article

Viral infections associated with the clinical use of monoclonal antibodies : Monoclonal antibody therapy and viral infections: update and beyondGENTILE, G; FOA, R.Clinical microbiology and infection. 2011, Vol 17, Num 12, pp 1769-1775, issn 1198-743X, 7 p.Article

Novel radiolabeled antibody conjugatesGOLDENBERG, D. M; SHARKEY, R. M.Oncogene (Basingstoke). 2007, Vol 26, Num 25, pp 3734-3744, issn 0950-9232, 11 p.Article

Monitoring Antigen-Specific Biologics: Current Knowledge and Future ProspectsZANDVLIET, Maarten L; VAN BEZOOIJEN, Jine S; BOS, Mariska A et al.Therapeutic drug monitoring. 2013, Vol 35, Num 5, pp 588-594, issn 0163-4356, 7 p.Article

The vasoactive peptide urotensin II stimulates spontaneous release from frog motor nerve terminalsBRAILOIU, E; BRAILOIU, G. C; MIYAMOTO, M. D et al.British journal of pharmacology. 2003, Vol 138, Num 8, pp 1580-1588, issn 0007-1188, 9 p.Article

Production of anti-idiotypic monoclonal antibody mimics for coronatineJONES, William T; HARVEY, Dawn; MITCHELL, Robin E et al.Food and agricultural immunology. 2002, Vol 14, Num 4, pp 301-311, issn 0954-0105, 11 p.Article

CD molecules 2006: Human cell differentiation moleculesZOLA, Heddy; SWART, Bernadette; ENGEL, Pablo et al.Journal of immunological methods. 2007, Vol 319, Num 1-2, pp 1-5, issn 0022-1759, 5 p.Article

Some aspects of the recombinantly expressed humanised superagonist anti-CD28 mAb, TGN1412 trial catastrophe lessons to safeguard mAbs and vaccine trialsMEHRISHI, Jitendra N; SZABO, Miklos; BAKACS, Tibor et al.Vaccine. 2007, Vol 25, Num 18, pp 3517-3523, issn 0264-410X, 7 p.Article